LRP2 and chronic kidney disease: The association between TMAO and soluble megalin, together with our in vitro findings showing that TMAO downregulates megalin expression in proximal tubular cells [20] and the reduced tissue megalin reported in CKD [17], supports a potential TMAO–megalin axis contributing to tubular dysfunction.